166 related articles for article (PubMed ID: 20063189)
1. Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide.
Lee SY; Jo YM; Chung WT; Kim SH; Kim SY; Roh MS; Lee SW
Rheumatol Int; 2012 Apr; 32(4):1065-8. PubMed ID: 20063189
[TBL] [Abstract][Full Text] [Related]
2. [Skin ulceration after leflunomide treatment in two patients with rheumatoid arthritis].
Jakob A; Porstmann R; Rompel R
J Dtsch Dermatol Ges; 2006 Apr; 4(4):324-7. PubMed ID: 16638062
[TBL] [Abstract][Full Text] [Related]
3. Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.
Alivernini S; Mazzotta D; Zoli A; Ferraccioli G
Drugs Aging; 2009; 26(5):395-402. PubMed ID: 19552491
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide.
Yoo HG; Yu HM; Jun JB; Jeon HS; Yoo WH
Mod Rheumatol; 2013 Jul; 23(4):709-15. PubMed ID: 22791271
[TBL] [Abstract][Full Text] [Related]
5. Leflunomide-associated infections in rheumatoid arthritis.
Jenks KA; Stamp LK; O'Donnell JL; Savage RL; Chapman PT
J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
[TBL] [Abstract][Full Text] [Related]
6. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
7. Recurrent pneumothorax associated with pulmonary nodules after leflunomide therapy in rheumatoid arthritis: a case report and review of the literature.
Kim SH; Yoo WH
Rheumatol Int; 2011 Jul; 31(7):919-22. PubMed ID: 19862529
[TBL] [Abstract][Full Text] [Related]
8. [Development and/or increase of rheumatoid nodules in RA patients following leflunomide therapy].
Braun MG; Van Rhee R; Becker-Capeller D
Z Rheumatol; 2004 Feb; 63(1):84-7. PubMed ID: 14991281
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate.
Lee SW; Park HJ; Kim BK; Han KH; Lee SK; Kim SU; Park YB
Arthritis Res Ther; 2012 Oct; 14(5):R232. PubMed ID: 23107811
[TBL] [Abstract][Full Text] [Related]
10. [Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review].
Molina Molina MI; Pinochet Paiva CM; Quezada Morales JI
Medwave; 2015 Dec; 15(11):e6350. PubMed ID: 26819061
[TBL] [Abstract][Full Text] [Related]
11. Leflunomide-induced pulmonary hypertension in a young woman with rheumatoid arthritis: a case report.
Alvarez PA; Saad AK; Flagel S; Mazzocchi O; Blanco MV
Cardiovasc Toxicol; 2012 Jun; 12(2):180-3. PubMed ID: 22270725
[TBL] [Abstract][Full Text] [Related]
12. [2 years data of controlled trials with leflunomide vs. methotrexate and leflunomide vs. sulfasalazine].
Krüger K
Z Rheumatol; 2002 Jun; 61(3):308-10. PubMed ID: 12219638
[No Abstract] [Full Text] [Related]
13. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis.
Popovic M; Stefanovic D; Pejnovic N; Popovic R; Glisic B; Obradovic S; Dimitrijevic M
Transplant Proc; 1998 Dec; 30(8):4135-6. PubMed ID: 9865325
[No Abstract] [Full Text] [Related]
15. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
Strand V; Cohen S; Schiff M; Weaver A; Fleischmann R; Cannon G; Fox R; Moreland L; Olsen N; Furst D; Caldwell J; Kaine J; Sharp J; Hurley F; Loew-Friedrich I
Arch Intern Med; 1999 Nov; 159(21):2542-50. PubMed ID: 10573044
[TBL] [Abstract][Full Text] [Related]
16. Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis.
Henes JC; Schedel J; Kanz L; Koetter I
Rheumatol Int; 2010 Mar; 30(5):709-12. PubMed ID: 20012622
[TBL] [Abstract][Full Text] [Related]
17. The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide.
Dziedziejko V; Kurzawski M; Safranow K; Chlubek D; Pawlik A
Pharmacogenomics; 2011 Jan; 12(1):41-7. PubMed ID: 21174621
[TBL] [Abstract][Full Text] [Related]
18. Safety evaluation of leflunomide in rheumatoid arthritis.
Keen HI; Conaghan PG; Tett SE
Expert Opin Drug Saf; 2013 Jul; 12(4):581-8. PubMed ID: 23668332
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
Mroczkowski PJ; Weinblatt ME; Kremer JM
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S66-8. PubMed ID: 10589360
[TBL] [Abstract][Full Text] [Related]
20. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
Geborek P; Crnkic M; Petersson IF; Saxne T;
Ann Rheum Dis; 2002 Sep; 61(9):793-8. PubMed ID: 12176803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
